Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
>
Issue Archive
> January 2008 Issue of MMM
January 2008 11 1 Issue of MMM
Editor's Desk
Make your own luck
This time last year we boldly saluted Merck as MM&M's first All-Star Company of the Year.
Features
MM&M All-Stars Company of the Year: Merck
When the going got tough, Merck got back to basics.
MM&M All-Stars Agency of the Year: AbelsonTaylor
Uncommonly good creative has helped standalone agency AbelsonTaylor stand out among its peers, garner acclaim and earn loyalty from clients.
MM&M All-Stars Large Pharma Marketing Team of the Year: Cymbalta (Eli Lilly)
Eli Lilly & Co. spent $128 million promoting Cymbalta (duloxetene) for the year through August, according to IMS Health.
MM&M All-Stars Small Pharma Marketing Team of the Year: Keppra (UCB, Inc.)
Since last year, when UCB, Inc. let users of its antiepileptic Keppra speak for the brand, patients have become an important visual and vocal component ...
Beyond the Patent: Extending the Life of Brands
With many of the industry's major blockbuster drugs coming off-patent in the next few years, pharmaceutical companies are scrambling to extend the life of their ...
Antidote
Antidote
In past columns I have defended the commonly used sleeping pill Ambien.
In Focus
Sky-high satellite space fees spur concerns
Funders of continuing medical education are becoming increasingly critical of satellite symposia.
MM&M All-Stars Media Brand of the Year: Sermo
On September 20, 2007, Sermo's founder and CEO Dr. Daniel Palestrant stepped up to the podium at the Health 2.0 conference in San Francisco and ...
Med Ed Report
Real-time education makes headlines
Do physicians need a CNN for CME? Some vendors think so and are implementing real-time educational offerings.
Rep. Waxman leak unlikely to suppress off-label guidance
The chairman of the House Committee on Oversight and Government Reform provoked industry exponents last month by leaking FDA draft guidance on off-label journal reprints.
Sermo launces HotSpots feature
Sermo launched its HotSpots feature, which contextually links to learning opportunities based on discussions taking place in the online physician community.
Pfizer's Kristofco comments on outcomes-oriented CME
During an MM&M webcast, Pfizer's Bob Kristofco, MSW, said pharma "continues to have an expectation for more outcomes-oriented CME," and that he expects grants from ...
Warner assumes new role at CME LLC
Melissa Warner has assumed the role of SVP and general manager of CME LLC.
Carlat vows pro-bono visits to doctor's offices
Daniel Carlat, MD, vowed pro-bono visits to doctor's offices as a way to repay $30,000 he earned from paid lecturing.
Whitcomb calls producing capable physician workforce "challenging"
In an editorial (Academic Medicine, Dec. 2007), Michael Whitcomb, MD, called producing a capable physician workforce "the most important challenge facing academic medicine."
Professional Media
Ascend pulls the plug on medical titles
Ascend Media is shedding its titles dependent on pharma ad revenue.
YouTube for docs is big at Temple
A would-be "YouTube for doctors" has posted 70 videos from Temple University.
Quadrant launches Physician's Travel & Meeting Network
Quadrant HealthCom launched Physicians' Travel & Meeting Network.
The Coalition for Healthcare Communication responds to Waxman
The Coalition for Healthcare Communication issued a statement in response to Rep. Henry Waxman's assault on pharmaceutical company's distribution of journal articles to doctors.
Wiley-Blackwell relaunches InfoPOEMs and InfoRetreiver products
Wiley-Blackwell is relaunching its InfoPOEMs and InfoRetriever products under the name Essential Evidence Plus.
Media Forum
How bad can journal ad drought get?
Many primary care journals have gotten dangerously thin this year, with some major medical publishers folding pharma ad revenue-dependent titles or putting them up for ...
E-marketing
Web Watch
As another new year rolls around, it's time to pull out the crystal ball and forecast how the Internet will evolve in 2008.
Revolution Health adds to its online health network
Revolution Health has acquired the online properties HealthTalk and SparkPeople in an attempt to challenge WebMD as the web's No. 1 health destination.
ePharma Summit discusses the future
The future of e-marketing will be in focus from Jan. 28- Jan. 30 when the some of the top names in e-marketing gather at Philadelphia's ...
Direct Marketing
Bill seeks to license pharma sales reps
The District of Columbia could become the first jurisdiction within the country to require the licensing of pharmaceutical sales representatives, pending the outcome of a ...
Docs rate top specialty reps in survey
Physicians were asked to rank the companies that have the best general sales reps, specialty sales reps, and medical science liaisons as part of "Specialty ...
Harte-Hanks adds to digital practice
Harte-Hanks has announced a series of changes and promotions as it enhances its digital practice area.
SK&A names Powell to newly created position
SK&A Information Services named Tim Powell senior director of sales, a newly created position.
HealthEd adds new members to its team
Vincent Dean Boyce joins HealthEd as senior interactive designer.
MediZine appoints Tolstoy Penkrat as senior promotion manager
MediZine announced the appointment of Sophia Tolstoy Penkrat as senior promotion manager.
DTC Report
DTC spend declined in third quarter
Could DTC be going the way of detailing?
Doc knocks DTC diagnostic ads
Writing in the December issue of Obstetrics & Gynecology, Dr. Erin Tracy said DTC ads for genetic tests are virtually unregulated and tests are costly ...
European Commission gets negative feedback on public consultation
The European Commission drew fire from patient and public health advocacy groups for a public consultation on matters regarding regulation of the pharma industry.
Mr. Mucus gets a new home
Mr. Mucus is going to work for Reckitt Benckiser, which bought Adams Respiratory Therapeutics, maker of the heavily advertised Mucinex franchise, for $2.3 billion.
Merck will continue DTC for Singulair, Januvia, says CFO
In an analyst call, Merck EVP and CFO Peter Kellogg said the company plans "continued DTC efforts for Singulair and Januvia as well as appropriate ...
Public Relations
PR View by Lynn Hanessian
The consumer has arrived in health.
PhRMA PPA spokesman snaps, scores bad press
Montel Williams, the talk-show host and spokesman for PhRMA's Partnership for Prescription Assistance, generated some unwelcome publicity when he lashed out at a 17-year-old intern ...
Wadler to head MWW health offering
MWW Group named Ame Wadler EVP, chief management officer and global healthcare practice leader.
Marketing Research
Vantage Point
In December we predicted a wild ride in 2008 for pharmaceutical marketing research.
Analytics pros more than just 'quants,' says study
Market research departments of a number of life science companies incorporate analytics functions, either partially or fully, a study shows.
New Web 2.0 metric not the old ROI
As pharma begins incorporating Web 2.0 tools in their marketing, many are unsure how to assess them.
Washington Insider
As I see it
Signs are everywhere that Washington is preparing for the next administration, whatever color it may be.
Gottlieb: FDA unprepared for follow-on biologics
Former FDA deputy commissioner for medical and scientific affairs Scott Gottlieb, now a senior fellow at the American Enterprise Institute, has expressed serious concerns about ...
Agency picks risk advisory panelist
The FDA's newly staffed Risk Communication Advisory Committee will begin reviewing risk communication issues in the first quarter of 2008.
Congress 'intimidating' FDA staffers
FDA review staffers have been subjected to so many requests to brief congressional staff members and supply documents that there is an "intimidating" atmosphere, according ...
DTC ads upset 'learned intermediary' role
State courts in West Virginia and New Jersey that declared the "learned intermediary" doctrine outmoded by DTC advertising were right on the money, according to ...
Bill would create public registry of drug company gifts to docs
A bill to create a public registry of drug company gifts to physicians will be introduced in 2008 by Rep. Peter DeFazio (D-OR).
Children's cough medicine concerns leads to OTC drug act
Responding to concerns about cough medicines labeled for children, Sen. Edward Kennedy (D-MA) and Rep. Henry Waxman (D-CA) have introduced the Non-Prescription Drug Modernization Act ...
FDA to create and staff inspection offices in China, India
The FDA plans to create and staff inspection offices throughout China and India, and possibly other countries.
Back Talk
Dems plans bad for pharma
January has kicked off the 2008 election cycle, with the Iowa caucuses and New Hampshire primaries taking the lead.
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
Pharmas are from Mars, Payers are from Venus
No-see docs are know-nothings when it comes to new drug info, study suggests
Study: Young Latinas are key decision makers, prefer English
How CDC's hep.-C testing advice benefits drugmakers now
Coach vs. cancer in BMS-backed awareness effort
Harvard urges faculty to ditch journals
Study: Young Latinas are key decision makers, prefer English
Pharma Report 2012: Get Back in Shape
Massachusetts gift ban under attack (again)
Pfizer, Crestor tops for global promotional spend in 2011
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Med Ed Report: Show Me the Money
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Bydureon catching on among endos but low profits expected, Amylin says
Did FDA's Vytorin warning negatively impact health outcomes?
Roundtable outlines path for publisher, pharma credibility
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Popular Topics
Acquisition
Adherence
App
Celebrity
Clinical Trial
Co-Marketing
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Medical Journal
Mobile
Sales Force